Vaxart, Inc.
VXRT· OTC
VXRTVaxart, Inc.
Filed Aug 6, 2026 · 10-Q · 37 days after period end · 0001437749-26-026289
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $27.19M | $39.73M | $6.40M | $1.36M |
| Net Income | -$13.49M | -$14.99M | -$16.47M | -$22.55M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaxart, Inc. · CIK 72444 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 6, 2026 · 37 d after period end
